Bladder cancer — all decisions

The Board denied service connection for bilateral hearing loss and tinnitus, as the evidence does not support a finding that these conditions are related to the Veteran's active service. The claim for bladder cancer was remanded due to an incomplete medical examination.

The Board granted service connection for a skin disability but denied service connection for depression, anxiety, bilateral hearing loss, tinnitus, diabetes mellitus, hemorrhoids, diverticular disease, erectile dysfunction, prostate cancer, bladder cancer, gallbladder issues, hernia, and residual scar from right inguinal hernia repair.

The Board granted an effective date of December 7, 2021, for the award of a 40 percent disability rating for bladder cancer residuals but denied a higher rating.

The Board granted service connection for bladder cancer due to exposure to Camp Lejeune contaminated water, resolving reasonable doubt in the Veteran's favor.

The Board denied an earlier effective date for the award of service connection for bladder cancer, finding no evidence of a claim prior to October 27, 2015.

The Board denied service connection for bladder cancer and hepatic steatosis, finding no evidence of these conditions during the Veteran's service or in the years following. The claims for left arm, left elbow, and back arthritis were remanded for further examination.

The Board granted service connection for prostate cancer due to exposure to ionizing radiation, secondary service connection for erectile dysfunction (ED), and special monthly compensation based on loss of use of a creative organ. The Board also granted service connection for bladder cancer as secondary to the previously established service-connected condition of prostate cancer.

The Board denied service connection for bladder cancer, type II diabetes mellitus, and peripheral neuropathy in the right and left lower and upper extremities as there was no evidence of herbicide exposure or a link to service.

The Board remands the claim for an initial rating greater than 20 percent for service-connected bladder cancer and dysfunction due to a pre-decisional duty to assist error, requiring a VA examination to fully evaluate the Veteran's condition.

The Board remands the matter to obtain a medical opinion regarding whether the Veteran's bladder cancer, which caused his death, was related to his service.

The Board remands the claims for a rating in excess of 40 percent for bladder cancer with residual voiding dysfunction and TDIU to correct a duty to assist error.

The appeal for a one-time payment of VA disability benefits for the month of February 2021 was denied due to legal regulations governing the effective dates of compensation benefit payments.

The Board denied service connection for bladder cancer, finding that the evidence did not support a direct link between the Veteran's condition and his military service or in-service exposure to contaminants.

The Board remands the claim for service connection for residuals of ureteral/bladder cancer to allow the AOJ to correct duty to assist errors.

The Board remands the issue of entitlement to an initial compensable rating for service-connected residuals of bladder cancer due to insufficient evidence regarding the frequency, severity, and duration of symptoms.

The Board denied the claim for service connection for the cause of the Veteran's death as new and relevant evidence had not been submitted to warrant readjudication.

The appeal for service connection for bladder cancer, right upper extremity peripheral neuropathy, and left upper extremity peripheral neuropathy is dismissed as the benefits sought have been granted.

The Board denied service connection for a bladder disability, to include bladder cancer, finding that the evidence did not support a relationship between the Veteran's current condition and his military service. The claim was remanded for further development regarding a cervical spine disability.

The Board denied an earlier effective date for the grant of service connection for bladder cancer and denied ratings in excess of 20 percent for lymphedema in both lower extremities.

The Board granted earlier effective dates for various conditions related to Parkinson's disease and service connection for bladder cancer due to exposure to Agent Orange.